Past Coverage of ACR 2014Past Coverage of ACR 2014 Return To RheumReports Home
Archive
November 19
-
FeaturedOver and Out from ACR 201410:14 PM ET — via Dr. Andy Thompson
-
If Your RA Patient Says ‘My Joints Are Killing Me’ They May Be Correct5:40 PM ET — via Dr. Janet Pope
-
Is Calprotectin a Better Biomarker than ESR or CRP?5:32 PM ET — via Dr. Lillian Barra
-
FeaturedIf You Don't Treat to Target, the Patient Won't Get Better!3:26 PM ET — via Dr. Janet Pope
-
Musings from the ACR: Subsequent Entry Biologics3:20 PM ET — via RheumReports
-
Patients with Ankylosing Spondylitis are Less Reactive2:06 PM ET — via Dr. Andy Thompson
-
NSAID Use May Protect Against CV Risk in Ankylosing Spondylitis2:04 PM ET — via Dr. Sherry Rohekar
-
FeaturedCardiovascular Disease Risk Assessment - What You Should Do and Why2:01 PM ET — via Dr. Andy Thompson
-
FeaturedAre Your Rheum Lexicon Matching Skills Up For the Test?1:52 PM ET — via Dr. Boulos Haraoui
-
Long-Term Outcomes Favourable for Rituximab Monotherapy in Cyroglobulinemic Vasculitis1:38 PM ET — via Dr. Lillian Barra